AMEX · Biotechnology

BiomX Inc. (PHGE) Stock

$0.20 +4.44% AMEX: PHGE Healthcare

Operating as a holding company, BiomX Inc. is dedicated to advancing technologies within the realms of defense, security, and essential infrastructure.

Valuation

MetricValue
Price$0.20
Market Cap$314570
P/E Ratio-0.01
P/B Ratio-0.56
P/S Ratio0.00
EPS (TTM)$-12.58
52-Week High$13.70
52-Week Low$0.18
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-694.46%
ROA-78.85%
ROCE-51.56%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-1.00
Current Ratio1.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-35.0M$-27.0M$-28.0M$-39.0M$-33.0M
Net Profit$-36.0M$-28.0M$-26.0M$-18.0M$-36.0M
EPS$-264.67$-180.31$-96.90$-27.93$-22.19
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$78.0M$46.0M$25.0M$43.0M$70.0M
Total Liabilities$30.0M$24.0M$22.0M$19.0M$72.0M
Cash$62.0M$31.0M$15.0M$18.0M$5.0M
Borrowings$20.0M$19.0M$15.0M$10.0M$1.0M

Latest News

BiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI Capabilities GlobeNewswire · Jul 10, 2026 BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure and Secure-Site Integration Capabilities GlobeNewswire · Jul 8, 2026 BiomX: Subsidiary Zorronet Commences Installation and Operation of AI-Powered Detection Systems Under Israel Railways Agreement GlobeNewswire · Jul 6, 2026 BiomX: Next-Gen Counter Drone Solutions will be Showcased by DFSL at ISC 2026 GlobeNewswire · Jun 24, 2026 BiomX Provides Update on Defense Technology Portfolio and Growth Strategy GlobeNewswire · Jun 18, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-28.0M$-29.0M$-21.0M$-37.0M$-26.0M
Investing Cash Flow$12.0M$-2.0M$2.0M$1.0M$0
Financing Cash Flow$0$0$0$28.0M$0
Net Cash Flow$26.0M$-31.0M$-16.0M$2.0M$-13.0M
Free Cash Flow$-31.0M$-29.0M$-21.0M$-37.0M$-26.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.03
FCF Yield-8265.25%
Quick Ratio1.00
Interest Coverage-33.00
Return 1Y-97.23%
Return 3Y-99.72%
Return 5Y-99.98%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADAPAdaptimmune Therapeutics plc $0.05 -3.00% -0.16 $75.16M 0.00%
BRTX $0.20 -2.11% -0.33 $1.83M 0.00%
DWTX $1.81 +3.14% 1.42 $3.45M 0.00%
EDSA $5.35 +1.90% -8.61 $51.54M 0.00%
ERNA $3.35 -3.46% 0.01 $1.05M 0.00%

About BiomX Inc.

Operating as a holding company, BiomX Inc. is dedicated to advancing technologies within the realms of defense, security, and essential infrastructure. Its diverse array of offerings features specialized solutions like counter-unmanned aerial vehicle systems, intelligent AI-powered command-and-control, comprehensive border and perimeter protection, expansive surveillance capabilities, and aerial fire suppression tools. The firm caters to a broad spectrum of clients, encompassing national defense organizations, primary government contractors, transportation management entities, local municipalities, and key infrastructure operators. BiomX Inc. commenced operations in 2015 and maintains its principal office in Dover, Delaware.

BiomX Inc. is led by CEO Marina Wolfson, employs 20 people, headquartered in US, publicly traded since 2019.

BiomX Inc. (PHGE) stock trades at $0.20 with a market capitalization of $314570. The stock is valued at a price-to-earnings (P/E) ratio of -0.01, price-to-book of -0.56, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.18 and $13.70, and currently trades 98.5% below its 52-week high.

On profitability, BiomX Inc. generates a return on equity (ROE) of -694.46%, return on capital employed of -51.56%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.biomx.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides